<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Osr Holdings Inc — News on 6ix</title>
<link>https://6ix.com/company/osr-holdings-inc</link>
<description>Latest news and press releases for Osr Holdings Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 13:50:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/osr-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a75878dffbe2df10be96.webp</url>
<title>Osr Holdings Inc</title>
<link>https://6ix.com/company/osr-holdings-inc</link>
</image>
<item>
<title>OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-executes-definitive-dollar815-million-global-license-agreement-for-vxm01-with-bcm-europe</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-executes-definitive-dollar815-million-global-license-agreement-for-vxm01-with-bcm-europe</guid>
<pubDate>Wed, 29 Apr 2026 13:50:00 GMT</pubDate>
<description>Largest shareholder pledges entire equity stake as collateral for milestone obligations, reinforcing alignment with public shareholders BELLEVUE, WA / ACCESS Newswire / April 29, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced that it has ...</description>
</item>
<item>
<title>OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-eliminates-dollar202-million-warrant-overhang-with-premium-priced-convertible-note</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-eliminates-dollar202-million-warrant-overhang-with-premium-priced-convertible-note</guid>
<pubDate>Thu, 09 Apr 2026 04:00:00 GMT</pubDate>
<description>BELLEVUE, WA / ACCESS Newswire / April 9, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) ("OSR Holdings" or the "Company") today announced a strategic transaction</description>
</item>
<item>
<title>OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-to-update-investors-at-the-emerging-growth-conference-on-april-1-2026</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-to-update-investors-at-the-emerging-growth-conference-on-april-1-2026</guid>
<pubDate>Mon, 30 Mar 2026 13:00:00 GMT</pubDate>
<description>BELLEVUE, WA / ACCESS Newswire / March 30, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the ...</description>
</item>
<item>
<title>OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-updates-dollar815-million-vxm01-licensing-deal-structure-to-capture-value-at-parent-level</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-updates-dollar815-million-vxm01-licensing-deal-structure-to-capture-value-at-parent-level</guid>
<pubDate>Mon, 23 Mar 2026 04:00:00 GMT</pubDate>
<description>BELLEVUE, WA / ACCESS Newswire / March 23, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced an updated structure of its previously disclosed binding</description>
</item>
<item>
<title>Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials</title>
<link>https://6ix.com/company/osr-holdings-inc/news/woori-io-an-osr-company-signs-nda-with-sinopharm-for-china-market-and-global-multicenter-trials</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/woori-io-an-osr-company-signs-nda-with-sinopharm-for-china-market-and-global-multicenter-trials</guid>
<pubDate>Thu, 19 Mar 2026 13:44:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary, Woori IO Co., Ltd. ("Woori IO"), has entered into a mutual non-disclosure agreement ("NDA") with Sinopharm Group Beijing Huahong ("Sinopharm"), the Beijing-based unit of Sinopharm Group and major state-owned healthcare and pharmaceutical distribution enterprise of China. This announcement is being made in accordance with Regulation FD to ensure b</description>
</item>
<item>
<title>Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities</title>
<link>https://6ix.com/company/osr-holdings-inc/news/woori-io-an-osr-company-signs-nda-with-sinopharm-to-explore-china-commercial-opportunities</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/woori-io-an-osr-company-signs-nda-with-sinopharm-to-explore-china-commercial-opportunities</guid>
<pubDate>Thu, 19 Mar 2026 12:55:00 GMT</pubDate>
<description>BELLEVUE, WA / ACCESS Newswire / March 19, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary, Woori IO Co., Ltd. ("Woori IO"), has entered into ...</description>
</item>
<item>
<title>OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-inc-granted-180-day-nasdaq-extension-reaffirms-strategic-momentum-24</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-inc-granted-180-day-nasdaq-extension-reaffirms-strategic-momentum-24</guid>
<pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
<description>BELLEVUE, WASHINGTON / ACCESS Newswire / March 5, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing innovative biomedical</description>
</item>
<item>
<title>CEO Statement to Shareholders</title>
<link>https://6ix.com/company/osr-holdings-inc/news/ceo-statement-shareholders-145000968</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/ceo-statement-shareholders-145000968</guid>
<pubDate>Mon, 02 Feb 2026 14:50:00 GMT</pubDate>
<description>BELLEVUE, WASHINGTON / ACCESS Newswire / February 2, 2026 /Reaffirming Strategic Execution and Long-Term Value Creation As the compliance deadline under the minimum bid requirement of NASDAQ approaches, we recognize that market volatility and uncertainty ...</description>
</item>
<item>
<title>OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-completes-woori-io-133000622</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-completes-woori-io-133000622</guid>
<pubDate>Tue, 27 Jan 2026 13:30:00 GMT</pubDate>
<description>BELLEVUE, WA / ACCESS Newswire / January 27, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced the official closing of its acquisition of Woori IO, the reaffirmation of long-term equity alignment by Woori IO's historical shareholders, and the ...</description>
</item>
<item>
<title>Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch</title>
<link>https://6ix.com/company/osr-holdings-inc/news/woori-io-an-osr-company-highlights-fda-clarification-on-non-medical-wearables-as-a-catalyst-for-accelerated-commercial-launch</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/woori-io-an-osr-company-highlights-fda-clarification-on-non-medical-wearables-as-a-catalyst-for-accelerated-commercial-launch</guid>
<pubDate>Thu, 22 Jan 2026 14:55:00 GMT</pubDate>
<description>Woori IO, an OSR company developing next-generation noninvasive glucose monitoring technologies, today commented on the U.S. Food and Drug Administration's recent clarification regarding non-medical-grade wearable devices, noting that the FDA's position establishes a regulatory framework highly conducive to Woori IO's commercialization strategy.</description>
</item>
<item>
<title>Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform</title>
<link>https://6ix.com/company/osr-holdings-inc/news/vaximm-appoints-sebastien-wieckowski-phd-as-chief-scientific-officer-to-advance-next-generation-oral-immunotherapy-platform</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/vaximm-appoints-sebastien-wieckowski-phd-as-chief-scientific-officer-to-advance-next-generation-oral-immunotherapy-platform</guid>
<pubDate>Fri, 16 Jan 2026 14:20:00 GMT</pubDate>
<description>Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneer in oral T-cell immunotherapies for cancer, today announced the appointment of Sébastien Wieckowski, PhD, as Chief Scientific Officer (CSO). This appointment strategically strengthens Vaximm's leadership with deep, long-standing expertise in the company's core technology.</description>
</item>
<item>
<title>Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings</title>
<link>https://6ix.com/company/osr-holdings-inc/news/woori-io-shareholders-approve-share-exchange-to-become-wholly-owned-subsidiary-of-osr-holdings</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/woori-io-shareholders-approve-share-exchange-to-become-wholly-owned-subsidiary-of-osr-holdings</guid>
<pubDate>Fri, 19 Dec 2025 16:50:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH) ("OSR Holdings"), a global healthcare holding company, today announced that the shareholders of Woori IO Co., Ltd. ("Woori IO"), a leading Korean medical device innovator in noninvasive glucose monitoring technology, approved a share exchange at an Extraordinary General Meeting ("EGM") held at Woori IO's headquarters in Jeonju, Korea. The approved share exchange will result in Woori IO becoming a wholly-owned subsidiary of OSR Holdings Co., Ltd. ("OSRK"), the Ko</description>
</item>
<item>
<title>Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months</title>
<link>https://6ix.com/company/osr-holdings-inc/news/vaximm-ag-an-osr-company-updates-term-sheet-with-bcm-europe-to-shorten-exclusivity-period-to-three-months</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/vaximm-ag-an-osr-company-updates-term-sheet-with-bcm-europe-to-shorten-exclusivity-period-to-three-months</guid>
<pubDate>Tue, 02 Dec 2025 14:53:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH) today provided an update regarding the previously announced non-binding term sheet between its subsidiary, Vaximm AG, and BCM Europe AG ("BCME"). The parties have agreed to shorten the exclusivity period from six months to three months, reflecting the strong alignment and confidence between Vaximm and BCME in advancing a definitive exclusive global licensing agreement for VXM01, Vaximm's first-in-class orally administered cancer immunotherapy platform.</description>
</item>
<item>
<title>OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-present-emerging-growth-200100669</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-present-emerging-growth-200100669</guid>
<pubDate>Mon, 01 Dec 2025 20:01:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. This presentation will provide investors and analysts with an updated overview of OSR Holdings' diversified healthcare platforms and strategic growth initiatives.</description>
</item>
<item>
<title>OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-appoints-scientific-co-161000810</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-appoints-scientific-co-161000810</guid>
<pubDate>Fri, 14 Nov 2025 16:10:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH) today announced the appointment of Dr. Andreas Niethammer, M.D., Ph.D., Vaximm AG's Chief Medical Offer and scientific co-founder, as Chief Executive Officer (CEO), effective December 1, 2025. Vaximm is a Swiss-German biotech company developing oral T-cell immunotherapies for cancer and a subsidiary of OSR Holdings, Inc.</description>
</item>
<item>
<title>OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-announces-woori-ios-133000397</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-announces-woori-ios-133000397</guid>
<pubDate>Thu, 06 Nov 2025 13:30:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH) today announced the key findings from a company-sponsored pilot study conducted by Woori IO, an OSR Company, in collaboration with Korea University Guro Hospital. The study, which took place from May 9 to September 12, 2023, evaluated the performance of the Glucheck blood glucose measurement system and validated its accuracy, stability, and usability across a representative participant group.</description>
</item>
<item>
<title>OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-signs-definitive-agreement-123000593</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-signs-definitive-agreement-123000593</guid>
<pubDate>Tue, 14 Oct 2025 12:30:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH) today announced that it has executed a definitive agreement to acquire Woori IO Co., Ltd. ("WORIO"), a pioneer in noninvasive glucose monitoring (NIGM), via a comprehensive share exchange. The acquisition reinforces OSRH's dedication to advancing biomedical innovation by adding a potential breakthrough technology for diabetes care, bringing truly needle-free glucose monitoring closer to patients globally and promising a safer, more convenient and accurate altern</description>
</item>
<item>
<title>OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-receives-nasdaq-minimum-213000731</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-receives-nasdaq-minimum-213000731</guid>
<pubDate>Tue, 09 Sep 2025 21:30:00 GMT</pubDate>
<description>OSR Holdings (Nasdaq: OSRH) today announced that on September 5, 2025, it received a written notification from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.</description>
</item>
<item>
<title>OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-host-virtual-investor-172900492</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-host-virtual-investor-172900492</guid>
<pubDate>Fri, 01 Aug 2025 17:29:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time).</description>
</item>
<item>
<title>OSR Holdings Provides Transparency Update on Equity Financing Instruments</title>
<link>https://6ix.com/company/osr-holdings-inc/news/osr-holdings-provides-transparency-equity-164500609</link>
<guid isPermaLink="true">https://6ix.com/company/osr-holdings-inc/news/osr-holdings-provides-transparency-equity-164500609</guid>
<pubDate>Thu, 31 Jul 2025 16:45:00 GMT</pubDate>
<description>OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovation approaches to health and wellness to support global health outcomes, today provided a transparency update regarding its Equity Line of Credit (ELOC) agreement with White Lion GBM Innovation Fund and related convertible instruments.</description>
</item>
</channel>
</rss>